← Leaderboards
Yunyan Jennifer Jennifer Zhang
Stanford University
$7,749,335
Attributed
$10,015,289
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,015,289 · 9
By mechanism
R01$8,645,837 · 5
K01$595,140 · 1
R03$389,880 · 2
R21$384,432 · 1
Top collaborators
- Fang Li6 shared
- Scott J Antonia3 shared
- Xiaoping Zhong3 shared
- Adela Rambi Cardones2 shared
Most similar at Stanford University
Same institution · by research overlap
- Paul A Khavari$40,653,927
- Christopher A Callahan$610,605
- Thomas D Wang$22,418,344
- John C Boothroyd$23,306,146
- Frederick T Chin$4,587,637
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingCellsInsightSignal TransductionMolecularProteinsPlayPathway InteractionsKeratinocyteBaseHomeostasisMalignant NeoplasmsRegulationSkinSignal PathwayEpidermisGrowthGeneticGenesTumor GrowthInflammatorySkin DisorderTissuesTranscription Factor
Grant awards (32)
Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy$535,077
R01 · FY2025 · CA · contact PI
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy$526,563
R01 · FY2025 · CA · contact PI
Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy$508,324
R01 · FY2024 · CA · contact PI
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy$500,236
R01 · FY2024 · CA · contact PI
Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy$524,375
R01 · FY2023 · CA · contact PI
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy$516,032
R01 · FY2023 · CA · contact PI
K63-Ubiquitin-mediated cell signal regulation in epidermis$354,200
R01 · FY2023 · AR · contact PI
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation$534,072
R01 · FY2022 · AI · contact PI
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation$450,777
R01 · FY2022 · AI · contact PI
K63-Ubiquitin-mediated cell signal regulation in epidermis$350,658
R01 · FY2022 · AR · contact PI
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation$541,109
R01 · FY2021 · AI · contact PI
K63-Ubiquitin-mediated cell signal regulation in epidermis$343,574
R01 · FY2021 · AR · contact PI
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation$566,998
R01 · FY2020 · AI · contact PI
K63-Ubiquitin-mediated cell signal regulation in epidermis$354,200
R01 · FY2020 · AR · contact PI
Keratinocyte targeted strategies for treatment of cutaneous GVHD$175,088
R21 · FY2020 · CA · contact PI
K63-Ubiquitin-mediated cell signal regulation in epidermis$353,650
R01 · FY2019 · AR · contact PI
Keratinocyte targeted strategies for treatment of cutaneous GVHD$209,344
R21 · FY2019 · CA · contact PI
THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS$79,500
R03 · FY2016 · CA · contact PI
THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS$79,500
R03 · FY2015 · CA · contact PI
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA$332,338
R01 · FY2014 · AR · contact PI
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA$322,164
R01 · FY2013 · AR · contact PI
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA$339,120
R01 · FY2012 · AR · contact PI
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA$339,120
R01 · FY2011 · AR · contact PI
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA$353,250
R01 · FY2010 · AR · contact PI
NF-kB, CDK4 and JNK in Epidermal Growth Regulation$120,014
K01 · FY2009 · AR · contact PI
CYLD Regulation of Epidermal Growth and Neoplasia$76,440
R03 · FY2009 · AR · contact PI
NF-kB, CDK4 and JNK in Epidermal Growth Regulation$119,506
K01 · FY2008 · AR · contact PI
CYLD Regulation of Epidermal Growth and Neoplasia$76,440
R03 · FY2008 · AR · contact PI
NF-kB, CDK4 and JNK in Epidermal Growth Regulation$119,014
K01 · FY2007 · AR · contact PI
CYLD Regulation of Epidermal Growth and Neoplasia$78,000
R03 · FY2007 · AR · contact PI
NF-kB, CDK4 and JNK in Epidermal Growth Regulation$118,535
K01 · FY2006 · AR · contact PI
NF-kB, CDK4 and JNK in Epidermal Growth Regulation$118,071
K01 · FY2005 · AR